Literature DB >> 22156496

Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses.

Julie A Swartzendruber1, Adam J Byrne, Paul J Bryce.   

Abstract

Histamine is an important allergic mediator, and studies have defined roles for both histamine 1 and 4 receptors in allergic airway inflammation. In this study, we show that histamine is necessary to generate IL-4-driven eosinophilic inflammation, as histamine-deficient mice cannot generate eosinophilic lung inflammation in response to intratracheal IL-4 and exogenous histamine restores responsiveness. This is histamine 2 receptor (H2R) dependent because H2R knockout mice fail to respond to IL-4, and a H2R agonist restores inflammation in histidine decarboxylase knockout. Furthermore, alveolar epithelial cells require H2R to produce CCL24, an eosinophil recruitment factor, whereas H2R blockade reduces CCL24 production from wild-type cells. In an allergic inflammation model, H2R knockout mice show significantly reduced eosinophilic inflammation and CCL24 expression. These data demonstrate a previously unidentified role for H2R in allergic inflammation and establishes a synergy between endogenous histamine and IL-4 that supports eosinophilic recruitment to the lung.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156496      PMCID: PMC3261133          DOI: 10.4049/jimmunol.1101795

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.

Authors:  Padraic G Fallon; Helen E Jolin; Philippa Smith; Claire L Emson; Michael J Townsend; Rosie Fallon; Philip Smith; Andrew N J McKenzie
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

2.  Mice lacking histidine decarboxylase exhibit abnormal mast cells.

Authors:  H Ohtsu; S Tanaka; T Terui; Y Hori; Y Makabe-Kobayashi; G Pejler; E Tchougounova; L Hellman; M Gertsenstein; N Hirasawa; E Sakurai; E Buzás; P Kovács; G Csaba; M Okada; M Hara; L Mar; K Numayama-Tsuruta; S Ishigaki-Suzuki; K Ohuchi; A Ichikawa; A Falus; T Watanabe; A Nagy
Journal:  FEBS Lett       Date:  2001-07-27       Impact factor: 4.124

3.  Critical role for IL-13 in the development of allergen-induced airway hyperreactivity.

Authors:  D M Walter; J J McIntire; G Berry; A N McKenzie; D D Donaldson; R H DeKruyff; D T Umetsu
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

4.  Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors.

Authors:  M Jutel; T Watanabe; S Klunker; M Akdis; O A Thomet; J Malolepszy; T Zak-Nejmark; R Koga; T Kobayashi; K Blaser; C A Akdis
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

5.  Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice.

Authors:  T Kobayashi; S Tonai; Y Ishihara; R Koga; S Okabe; T Watanabe
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  Desloratadine inhibits allergen-induced airway inflammation and bronchial hyperresponsiveness and alters T-cell responses in murine models of asthma.

Authors:  Paul J Bryce; Raif Geha; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2003-07       Impact factor: 10.793

7.  Identification of a histamine H4 receptor on human eosinophils--role in eosinophil chemotaxis.

Authors:  Mark O'Reilly; Robbin Alpert; Stephen Jenkinson; Ronald P Gladue; Shane Foo; Steven Trim; Beate Peter; Mike Trevethick; Mark Fidock
Journal:  J Recept Signal Transduct Res       Date:  2002 Feb-Nov       Impact factor: 2.092

8.  Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.

Authors:  Andrew Menzies-Gow; Sun Ying; Ian Sabroe; Victoria L Stubbs; Dulce Soler; Timothy J Williams; A Barry Kay
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

9.  Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice.

Authors:  Charles Perkins; Noriko Yanase; George Smulian; Lucy Gildea; Tatyana Orekov; Crystal Potter; Frank Brombacher; Bruce Aronow; Marsha Wills-Karp; Fred D Finkelman
Journal:  J Exp Med       Date:  2011-04-04       Impact factor: 14.307

10.  Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation.

Authors:  Frank Blaeser; Paul J Bryce; Nga Ho; Vidya Raman; Fatma Dedeoglu; Debra D Donaldson; Raif S Geha; Hans C Oettgen; Talal A Chatila
Journal:  J Exp Med       Date:  2003-10-13       Impact factor: 14.307

View more
  4 in total

Review 1.  Mast Cell Interactions and Crosstalk in Regulating Allergic Inflammation.

Authors:  Tania E Velez; Paul J Bryce; Kathryn E Hulse
Journal:  Curr Allergy Asthma Rep       Date:  2018-04-17       Impact factor: 4.806

2.  Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.

Authors:  Sarita Sehra; Ana P M Serezani; Jesus A Ocaña; Jeffrey B Travers; Mark H Kaplan
Journal:  J Invest Dermatol       Date:  2016-03-25       Impact factor: 8.551

Review 3.  Granulocyte-targeted therapies for airway diseases.

Authors:  Luciana P Tavares; Hong Yong Peh; Wan Shun Daniel Tan; Hadas Pahima; Pasquale Maffia; Ekaterini Tiligada; Francesca Levi-Schaffer
Journal:  Pharmacol Res       Date:  2020-05-04       Impact factor: 7.658

Review 4.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.